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upon Duke and Northern New England survival models. Pro-post changes were evalu- 
ated with McNemafs test for matched-pair data or the sign test as appropriate. 
Rseulte: We enrolled 200 patients (mean age 64.6 years, 56,5% male, 66.5% white, 
32% with more than high school education) during the study period. Prior to viewing the 
SDP, 89% of patients wanted more information about IHD. After viewing the SDP, 39% 
(26/66) of patients who were initially undecided about a treatment choice were able to 
select a treatment (p=0.001). Patients reported greater comfort in selecting a treatment 
(p=0.0002), greater confidence in their chosen treatment (p=0.0002), and less anxiety 
with the decision process (p=0.0001). In addition, patients reported greater comfort with 
their knowledge (p=0.0002) and less desire to know more about IHD (p=0.0002). 64% of 
patients rated the SDP as "very helpful" or "most helpful" in the decision process. 
Conclusion: The majority of patients considering coronary revasculadzation report a 
need for more information. These data demonstrate that provision of information through 
an electronic format can address this need and consequently enable patients to take a 
more active role in their care. With rising time constraints on health care providers, evolv- 
ing technologies have the potential to supplement physicians in informing major treat- 
ment decisions. 
3:48 p.m. 
1144MP-125 Use of Wireless Local Area Network Systems in 
Coronary Care Units in Canadian Hospitals 
I<ok-Swano Tan. Wayne Tymchak, Irwin Hinberg, Richard F. Davies, University of Ottawa 
Heart Institute, Ottawa, Canada, Medical Devices Bureau, Health Canada, Ottawa, 
Canada. 
Computer-based wireless local area network (LAN) systems have the potential to provide 
real time access to medical information at the bedside. The purpose of this study was to 
address concerns about the susceptibility of electromedical devices in a coronary care 
unit (CCU) to electromagnetic nterference (EMI) from wireless I_AN systems. It was con- 
ducted as a collaboration between the Medical Devices Bureau of Health Canada, the 
University of Ottawa Heart Institute, and University of Alberta Hospitals as part of the 
Acute Care Extended Surveillance (ACES) project. 
The system tested consisted of a PC server linked to a Lucent Wavepoint II fixed emitter 
located centrally in the CCU just below ceiling level, which communicated with Fujitsu 
Stylistic LT mobile pen based computers equipped with a Lucent Silver Turbo PCMCIA 
transceivers. Output from both fixed and mobile transceivers was measured at varying 
distances. The susceptibility to EMI from both was evaluated for a total of 41 medical 
devices from 22 different device classes in the CCU of both hospitals. Each device was 
tested 1) at the usual operating distances and 2) as close as possible to the transceivers. 
The power output of the Wavepoint II transceiver was less than 100 mW and generated 
an electrical field strength of 0.1 V/m at one meter, compared to the background electric 
field strength of <0.5 V/m at each test site. The mobile transceiver produced mild distor- 
tion of s diagnostic ultrasound image when held within 0.2 meters of the ultrasound 
probe. Otherwise, no interference was seen with the functioning of any medical device, 
even at minimal distances. No tested medical device interfered with RF I_AN functioning. 
All wireless LAN technology should be tested for interference with potentially susceptible 
devices by the hospital before implementation. These findings suggest that wireless LAN 
systems may be acceptable for use in most hospitals. This technology may reduce the 
cost of computerization by eliminating the need for hard wiring and by allowing each 
mobile workstation to be used for several patients. 
4:00 p.m. 
1144MP-126 New Uses of the VA's Multimedia Electronic Patient 
Record in Patient Care, Research, and Educetlon 
Ross D. Fletcher, Ruth E. Dayhoff, Amanda C. Graves, Chiao M. Wu, Kevin Crawford, 
Christopher McManus, Ronald E. Jones, Department of Veterans Affairs, Washington, 
DisL of Columbia, Georgetown Universi~ Washington, DisL of Columbia. 
Background: The VA multimedia electronic patient record, which is available at over 1500 
workstations throughout he Washington VA Medical Center, presents the entire patient 
record using a GUI based patient chart, with all diagnostic images, including ECGs, and 
cine loops. The electronic patient record is available remotely and, using the VA's Heeith- 
eVet initiative, includes a Web based record a patient can share with third party physi- 
cians. System: Using standard off-the-shelf components, the VA has built a distributed 
network that manages all aspects of the clinical record. Capture stations collect images, 
which are saved to an optical jukebox and linked to the legacy text based database. A 
fiber optic backbone distributes information to the data closets. A 10/100-MB link ensures 
the timely display of large image files such as x-rays and cineangiograms. Cardiology 
images include echoes, coronary arteriograms, ventriculograms, MUGA, thallium stud- 
ies, X-rays, and ECG tracings, as well as other multispeciaity images. The Cardiology 
database includes records of over 7,272 Caths; 7,494 Holtars; 86,264 ECGs; 22,786 
Echocardingrams; 11,213 ETFs; and 1,934 EPs. Results: Non-patient care duties have 
been significantly streamlined as all notes, orders, reports, and discharge summaries are 
wdtten directly into the workstation. Delinquent charts have all but been eliminated. Lab 
values can be compared and plotted. Diagnostic images are available with the chart at 
any point of care. All patient data is on-line and can be used for reminders, which directly 
order necessary tests. The database is being mined for research purposes, which has 
resulted in new treatment protocols being developed and tested for diabetes and hyper- 
tension. Patient education is improved since the patient chart can be explained in the 
doctor's office. Patients participate in their treatment using the Health-eVer web based 
chart by entering home based measurements and treatments by third party physicians. 
Conclusions: Clinicians have a tool that provides complete Cardiolngic and other patient 
information, which enhances their productivity and provides better patient care. 
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4:12 p.m. 
1144MP-127 Can Two-Dimensional Echocardiogrephy Accurately 
Measure Perlcardlal Effusion Volume? 
Anita M. Prakash, Yino Sun, Salvatore A. Chiaremida, Jiang Wu, Richard J. Lucadello, 
Our Lady of Mercy Medical Center, Bronx, New York, University of Rhode Island, 
Kingston, Rhode Island. 
Background: Assessing the severity of pericardial effusion is an important clinical prob- 
lem and has been based on qualitative or semi-quantitative approaches. A computer 
algorithm was developed previously for measuring pericardial effusion volume (PEV) 
with 2D echocardiography. This study was conducted to assess its accuracy for clinical 
use. Methods: Pericardial and epicardial borders were manually traced on digitized 2D 
echocardiograms. Each border was used to estimate a volume by use of the proposed 
3D-disk method. The conventional area-length method was also used for comparison. 
The PEV, determined by the difference between the pedcardial and cardiac volumes, 
was compared to the surgically drained volume of pedcardial fluid. To assess the intrinsic 
error of the computational methods, an in-vitro study was conducted by use of a phantom 
consisting of two latex balloons, one positioned inside the other to mimic the geometry of 
the pericardium. The balloons were filled with known amounts of water and imaged by 
use of a 2D echocardiography system. The intrs-observer and inter-observer variabilities 
of the border tracing were evaluated with two clinical cases, each measured 10 times by 
10 different observers. Comparison between the estimated PEV (y) and the known PEV 
(x) was done by linear regression and the Bland-Aitman analysis. Results: The clinical 
study included 20 pericardial window procedures among 19 patients. The drained PEV 
ranged from 100 cc to 1200 cc. With the 3D-disk method the linear regression resulted in: 
y = 0.81 x + 120 cc; r = 0.91, p < 0.0001. The limits of 95% confidence from the Bland- 
Aitman analysis were between -243 cc and 278 cc. The percent error, determined by the 
standard error of the estimate (114 cc) over mean (548 cc), was 20%. By contrast, the 
phantom study showed a correlation coefficient of 0.98 and a pement error of 6%. The 
intra-observer vadability was 1.5% and inter-observer variability was 3%. The aree- 
length method was less accurate than the 3D-disk method and generally underestimated 
the PEV. Conclusion: The 3D-disk method and 2D echocardiography provide quantitative 
assessment of PEV in the clinical situations with accuracy within 20%. 
4:24 p.m. 
1144MP-128 Automated Analysis of Phase-Contrast Magnetic 
Resonance Images in the Assessment of Endothellum- 
Dependent Flow-Mediated Dilation 
Pino Tan. Wake Forest University, School of Medicine, Medical Engineering Dept, 
Winston-Salem, North Carolina. 
Measurement of flow mediated artedal dilation (FMAD) provides information regarding 
the status of peripheral arterial endothelial function. Although phase-contrast magnetic 
resonance imaging (PC-MRI) can be used to measure FMAD, the manual analysis of 1 
study (tracing regions of interest and processing data on 100 images) can require 6 or 
more hours. To enhance the clinical utility of PC-MRI assessment of FMAD, we hypothe- 
sized that an automated technique (Multi-Stage Intensity Thrasholding or MSIT) for 
determining femoral artedal area and flow before and after cuff inflation over the thigh 
could be used to evaluate FMAD in a rapid, accurate, and reproducible manner. In both 
normal subjects (n:6) and in NYHA class III CHF patients (n=8), we measured the femo- 
ral artery cross-sectional area at 30 second intervals before, during and after an isohemic 
stimulus (5 minutes suprasystolic thigh cuff inflation) using PC-MRI. Image parameters 
included a 7 mm slice thickness, a 13 cm field of view (FOV), a 256x256 matrix, 40o flip 
angle, an 18 ms repetition time (TR), a 6.7 msec echo time (TE), a 150 cm/sec velocity 
encoding ration, and the incorporation of k-space segmentation so as to yield 7 or more 
frames (temporal resolution of 90 to 105 ms) per cardiac cycle. Compared with manual 
analysis, automated .analysis detected a similar percentage change in FMAO between 
young healthy individuals (15.5% vs 16.7%) and patients with congestive heart failure 
(3.2% vs 3.0%). The correlation between percentage of FMAD traced manually and that 
analyzed automatically was good (r--0.89). Automated analysis time for 100 images aver- 
aged 10 minutes vs 6 hours for manual analysis. In conclusion, rapid, accurate assess- 
ments of femoral artery FMAD can be obtained using multi-stage intensity thresholding. 
This methodology allows for the rapid clinical assessment of peripheral arterial endothe- 
lial function in patients with cardiovascular disease. 
4:36 p.m. 
1144MP-129 Automatic Detection of Left Ventricular Contours From 
Contrast Echocerdlogrephy: Comparison With Cardiac 
Clne Magnetic Resonance 
Made-Aurora Morales. Olaf Roddguez, Vincenzo Positano, Martha Morelos, Annamarts 
Sironi, Mirko Passera, Massimo Lombardi, Daniela Royal, CNR Clinical Physiology 
Institute, Pisa, Italy. 
Contrast agents are able to improve endocardial border delineation in echocardiography; 
however, manual outline of ventdcular contours to dadve LV volumes and ejection frac- 
tion remains subjective and time consuming. The aim of this study was to evaluate 
whether an automatic contour detection method of contrast echo images may provide 
reliable estimates of LV volumes as compared to cine Magnetic Resonance Imaging 
(MRI). In 11 patients with different degrees of ventdcular dysfunction, LV volumes were 
measured by cine MRI and by trensthoracic, second harmonic echocardiography after 
the administration of the contrast agent Levovist (Schedng AG, 400 mg/ml I.V. in 2 min- 
utes). Contrast echo images were analyzed bot manually (tracing the contours of LV cav- 
ity) and automatically. To increase signal to noise and contrast o noise ratio, the images 
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were processed by a non linear anisotropic filter and LV edges were identified using an 
active contour algorithm, guided by image gradient. End-diastole and end-systole were 
identified based on R wave synchronization and cavity size, respectively. In both meth- 
ods, LV volumes were calculated by the modified Simpson's rule. A commercially avail- 
able automatic image analysis method was utilized for endocardial detection in MRI (Fast 
Cine, Leiden University version 4.0). Manual analysis showed a good correlation with 
MRI volumes (correlation coefficient r= 0.88); using this automatic approach the corraia- 
fion was still good (r = 0.82); however, LV diastolic and systolic volumes were higher for 
MRI (206 ± 96m1. and 148 ± 105 ml ) than for contrast echo assessed both manually (177 
± 88 mL and 108 ± 73, p= <.001) and automatically (179 ± 104m1. and 107 ± 79 ml. , 
p=.<001). In conclusion, automatic endocardisf border delineation is feasible on contrast 
enhanced images. Despite manual detection on contrast images showed a better corre- 
lation with MRI for LV contour analysis, preliminary results show that this method may 
represent a promising approach for automatic LV function assessment. 
4:48 p.m. 
1144MP-130 QuanUtsUve Three-Dimensional Intravaecular 
Ultrasound: Improvements Toward Semi-Automated 
Border Detection Including the Stent Border 
Jouka Di!kstre, Gerhard Koning, Joan C. Tuinenburg, Pranobo V. Oemrawsingh, Johan 
H.C. Reiber, Leiden University Medical Center, Leiden, The Netherlands. 
Background: IntreVascular UltraSound (IVUS) is a catheter-based technique, which 
provides real-time high-resolution images of the entire arterial wall. The technique is 
used often to monitor the stent placement or to visualize in-stent restenosis. Automation 
of the boundary detection of the stent, lumen, and vessel reduces the required analysis 
time and the subjectivity of the manual tracing procedure. The three-dimensional recon- 
struction permits an advanced assessment of the morphology. 
Methods: The (semi-)automated approach is a combination of transversal and longitudi- 
nal contour detection techniques and is based on a model of the vessel and uses knowl- 
edge about the morphologic structures. The stent contour is detected based on the high 
intensity of the stent struts as compared to other structures and their expected location in 
the vessel wall based on an approximately cimuiar model. The detection method itself is 
able to perform corrections based a continuously three-dimensional structure. 
Results: In a set of 150 slices from different pullback sedas (acquired with Boston Scien- 
tific and EndoSonics equipment) the automatically detected stent boundaries were com- 
pared to manually drawn stent boundaries. The comparison of the cross-sectional stent 
areas for the manually traced and automatically detected boundadss resulted in an r- 
value of 0.99. In a set of 50 pullback runs (acquired with Endosonica equipment) the 
entire stented segment was analyzed automatically and the most distal and the most 
proximal slice in a continuous series of slices containing stent struts was selected to 
assess the stent length. The companson of these distances with the original stent lengths 
resulted in an average overestimation of 0.35 +/- 1.42 mm by IVUS. The start and end 
point of a stent is not well defined because the catheter moves in and out the stent, due 
to cardiac motion. 
Conclusion: Due to the flexible use of more than two longitudinal cutpianes and the 
advanced knowledge-guided contour detection approech, the new IVUS analysis system 
has proven to be suitable for clinical research studies. The inclusion of the stant bound- 
ary is very useful for stent studies e.g. to study the effect of drug coated stents. 
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4:00 p.m. 
411-1 A Prospective, Bl inded DeterminaUon of the Natural 
History of Aspir in Resistance Among Stable Cardiac 
Patients 
Patricia A. Gum. Kandica Kottke-Marchant, Eric J. Topoi, The C/eve/and C/inic 
Foundation, C/eveiand, Ohio. 
Background. Aspirin resistance, as defined by comprehensive, ax vivo piatalet function 
testing as well as presumed clinical unresponsiveness to aspirin, has been previously 
reported by our group and others. However, little information exists linking the laboratory 
documentation of aspirin resistance and long-term clinical events. 
Methods. We prospectively enrolled 326 stable cardiac patients from 1997 to 1999 on 
aspidn (325 mg/day for > 7 days) and no other antiplatalst agents. We tested them for 
aspidn sensitivity by optical piatelat aggregation using adenosine diphosphata (ADP) and 
arachidonic acid (AA) and followed them for clinical events. The primary outcome was 
the composite of death, myocardial infarction (MI), or carebrovascuiar accident (CVA). 
Mean follow-up was 679 ± 185 days. Aspirin resistance was defined as a mean aggrega- 
tion of > 70% with 10 p. M ADP and _> 20% with 0.5 rag/ml hA. 
Results. Of the patients studied, 17 (5.2%) were aspirin resistant and 309 (94.8%) were 
not aspirin resistant. Dudng long-term follow-up, aspirin resistance was associated with a 
significantly increased risk of death, MI, or CVA compared to patients who were aspidn 
sensitive (24% vs 10%, HR 3.12, 95% CI (1.10-8.90), p=0.03). Stratified multivadata 
analyses identified elevated piatelet count, advancing age, history of congestive heart 
failure and aspirin resistance to be independently associated with major adverse long- 
term outcomes (HR for aspirin resistance 4.14, 95% CI (1.42-12.06), p=0.009). 
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Conclusion. This study is the first prospective determinant of the natural history of aspi- 
rin resistance, documenting a greater than 2-fold increase in the risk of major adverse 
events associated with aspirin resistance. 
4:15 p.m. 
411-2 Loss of Thrombomodulin Expression Impairs Vein Graft 
Thromboreslstance 
Antony Y. Kim. Kenneth Lee Baughman, Peter L. Walinsky, Frank D. Kolodgie, C. E. 
Bean, Jason Sperry, Clayton Deming, Eric Peck, Jay Shake, Gregory Ang, Chades 
Eamon, Rsnu Virmani, Jeffrey Rada, Johns Hopkins Schoo/ of Medicine, Baltimore, 
Mary~and. 
Background: Thrombosis is the major cause of eady vein graft failure. The aim of this 
study was to determine whether alterations in the expression of the anticoagulant pro- 
teins, thrombomodulin (TM) and the endothelial call protein C receptor (EPCR), impair 
endothelial thromboresistance and contribute to vein graft failure. Methods and 
Results: Immunohistochamical nalysis of autologous rabbit vein grafts revealed that 
the expression of TM, but not EPCR, was reduced by 98% 3 days after implantation, with 
gradual but incomplete recovery by 42 days. This resulted in up to a 95% reduction in the 
capacity of the grafts to activate protein C and was associated with increased bound 
thrombin activity, that peaked on day 7 at 28.7" 3.8 mU/cm 2 and persisted for over 14 
days. Restoration of TM expression using adenovirus vector-mediatad gene transfer sig- 
nificantly enhanced the capacity of grafts to activate protein C and resulted in a near 80% 
reduction in bound thrombin activity on day 7, to levels comparable to normal veins (5.7" 
0.4 vs. 5.2 " 1.1 mU/cm 2, respectively, p= 0.74). Surprisingly, neointima formation was 
not affected by this inhibition of local thrombin generation. Conclusions: These results 
suggest that eady loss of TM expression enhances local thrombin generation that con- 
tributes to early vein graft failure due to thrombosis, but does not contribute significantly 
to late vein graft failure due to neointimal hyperplasia. 
4:30 p.m. 
411-3 Improvement in Diastolic Suction In Patients With 
Hypertrophic Obstructive Cardiomyopathy After Septsl 
Ablation 
Aleksendr Rovner. Marta Sitges, Rebecca Smith, Nell L. Greanborg, Irmian Yiassak, 
Takahiro Shiota, Murat E. Tuzcu, Nicholas Smadira, Harry M. Lever, James D. Thomas, 
Mario J. Garcia, Department of Cardiovascular Medicine, The Clave~and C/inic 
Foundation, C/eve/and, Ohio. 
Background: Saptal alcohol ablation (PTSA) is an effective treatment in hypertrophic 
obstructive cardiomyopathy (HOCM). Intraventricuiar pressure gradient (IVPG) is a novel 
method to evaluate diastolic function. Our aim was to analyze the IVPG and diastolic 
function in HOCM patients with PTSA. 
Methods: 19 patients had an echocardiogram performed at baseline end after PTSA 
(mean follow up 5.6-J:1.2 months). Diastolic parameters were obtained using PW-Doppler 
through the mitral valve (E, A, DT), pulmonary venous flow (S, D), mitral annulus tissue 
Doppler imaging (Ea). Color M-mode was used to obtain the flow propagation velocity 
(Vp) through the mitral valve and to calculate IVPG oft-line using custom written soft- 
ware. LV dimensions were obtained. LV outflow tract (LVOT) gradient was calculated. 
Results: LVOT gradient decreased from 62±10 to 29:t:5 mmHg (p<0.001), severity of 
mitrel regurgitation (MR) decreased from 2.1:L-0.2 to 1.3!-0.2 (p<0.01). The septal size 
decreased from 2.3i~-0.09 to 1.9t0.05 mm (p<0.01). Diastolic results are shown in the 
Table. 
IVPG Vp (era/ E/A DT (ms) S/D EWp E/Ea 
(mmHg) s) 
Pre 1.5t-0.2 48+5 1.5±0.2 258±15 1.2!-0.1 2.2_+0.2 14.?_.-~.5 
Post 2.6+0.3* 74+7* 0.9t-0.1" 256+12 1.3-~0.1 1.3i0.1" 11.3±1.3 
*p<0.01 vs Pre. 
The increase in IVPG correlated with the increase in Vp (r=0.5) and with the decrease in 
LVOT gradient (r=-0.6), F_Np (r=-0.5), E/Ea (r=-0.7), (all p<0.05), and decrease in MR 
(r=-0.7, p<0.01). No correlation was found between the increase in IVPG and decrease in 
E/A, S/D and DT. 
Conclusion: IVPG is a reliable indicator of diastolic function improvement in HOCM after 
PTSA as indicated by the increase in IVPG and change in other diastolic parameters. 
4:45 p.m. 
411-4 L-Arginine Protects Human Heart Cells From Simulated 
Anoxia and Reoxgenation 
Subodh Verma. Noritsugu Shiono, Ran-Ks Li, Donald A. Miokle, Paul W. Fedak, Richard 
D. Waissf, University of Toronto, Toronto, Ontario, Canada. 
The present study was conducted to evaluate the direct affects of L-arginine in a human 
ventricular heart cell model of simulated isohemia and reperfusion independent of alter- 
nate cell types such as endothelial cells, neutrophils, platelets or fibroblasts. Human ven- 
tdcuiar heart call cultures were subjected to 90 minutes of low volume isohemia and 30 
minutes of reperfusion. L-arginina (0-5.0 mM) was administered udng the pre-ischemic 
period or dudng the reperfusion phase. Nitric oxide synthase (NOS) activity, nitric oxide 
(NO) production, cGMP levels and cellular injury were assessed. To evaluate the effects 
of L-arginine on cell signaling, the effects of NOS antagonist (L-NAME), NO donor 
(SNAP), guanylate cyciase inhibitor (methylene blue), cGMP analogue (8-BrCGMP) and 
KAT P antagonist (glibenclamide) were examined. Our data indicate, that ischemia and 
reperfusion increased NOS activity and facilitated the conversion of L-arginine to NO, 
